U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 21:22:06 GMT 2025
Edited
by admin
on Mon Mar 31 21:22:06 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
V00Y10W60W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LINTUZUMAB
INN   WHO-DD  
INN  
Official Name English
lintuzumab [INN]
Preferred Name English
SGN-33
Code English
HUM195
Code English
HUMA-195-GELONIN
Code English
HUM-195
Code English
IMMUNOGLOBULIN G1 ANTI-(HUMAN CD33 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HUM195 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUM195 .KAPPA.-CHAIN, DIMER
Common Name English
Lintuzumab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
FDA ORPHAN DRUG 235106
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
FDA ORPHAN DRUG 158502
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
FDA ORPHAN DRUG 238007
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
EU-Orphan Drug EU/3/09/627
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
Code System Code Type Description
CAS
166089-32-3
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
PRIMARY
NCI_THESAURUS
C1716
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
PRIMARY
SMS_ID
100000086149
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109150
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
PRIMARY
EVMPD
SUB02929MIG
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
PRIMARY
WIKIPEDIA
LINTUZUMAB
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
PRIMARY
INN
7580
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
PRIMARY
FDA UNII
V00Y10W60W
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
PRIMARY
DRUG BANK
DB14877
Created by admin on Mon Mar 31 21:22:06 GMT 2025 , Edited by admin on Mon Mar 31 21:22:06 GMT 2025
PRIMARY
From To
1_22 1_96
1_143 1_199
1_219 3_218
1_225 2_225
1_228 2_228
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_219 4_218
2_260 2_320
2_366 2_424
3_23 3_92
3_138 3_198
4_23 4_92
4_138 4_198
Related Record Type Details
MYELOID CELL SURFACE ANTIGEN CD33
TARGET -> INHIBITOR
Related Record Type Details
LINTUZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:ESTIMATED CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966